Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recombinant vaccines for COVID-19
Tushar Yadav, Nishant Srivastava, Gourav Mishra, et al.
Human Vaccines & Immunotherapeutics (2020) Vol. 16, Iss. 12, pp. 2905-2912
Open Access | Times Cited: 103

Showing 26-50 of 103 citing articles:

A global survey in the developmental landscape of possible vaccination strategies for COVID-19
Amin Gasmi, Shvetha Srinath, Maryam Dadar, et al.
Clinical Immunology (2022) Vol. 237, pp. 108958-108958
Open Access | Times Cited: 16
Recombinant Protein Vaccines against Human Betacoronaviruses: Strategies, Approaches and Progress
Angelina Kovalenko, Ekaterina M. Ryabchevskaya, Ekaterina A. Evtushenko, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1701-1701
Open Access | Times Cited: 9
Noninfectious Uveitis Risk After COVID-19 Vaccination: A Nationwide Retrospective Cohort Study
M. Chang, Hae Rang Kim, Sunyeup Kim, et al.
American Journal of Ophthalmology (2023) Vol. 258, pp. 22-31
Closed Access | Times Cited: 9
Preliminary evidence on the safety profile of BNT162b2 ( Comirnaty ): new insights from data analysis in EudraVigilance and adverse reaction reports from an Italian health facility
Michele Gringeri, Giulia Mosini, Vera Battini, et al.
Human Vaccines & Immunotherapeutics (2021) Vol. 17, Iss. 9, pp. 2969-2971
Open Access | Times Cited: 19
Acquired Thrombotic Thrombocytopenic Purpura Following Inactivated COVID-19 Vaccines: Two Case Reports and a Short Literature Review
Imen Ben Saida, Iyed Maatouk, Radhouane Toumi, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1012-1012
Open Access | Times Cited: 14
Current clinical status of new COVID-19 vaccines and immunotherapy
Diksha Nagpal, Shakti Nagpal, Deepak Kaushik, et al.
Environmental Science and Pollution Research (2022)
Open Access | Times Cited: 14
ANCA-Associated Vasculitis May Result as a Complication to Both SARS-CoV-2 Infection and Vaccination
Michalis Christodoulou, Fotini Iatridi, George Chalkidis, et al.
Life (2022) Vol. 12, Iss. 7, pp. 1072-1072
Open Access | Times Cited: 13
Recurrent Multiple Evanescent White Dot Syndrome (MEWDS) Following First Dose and Booster of the mRNA-1273 COVID-19 Vaccine: Case Report and Review of Literature
Matias Soifer, Nam V. Nguyen, Ryan Leite, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1776-1776
Open Access | Times Cited: 13
Parental awareness and utilization of meningococcal serogroup B vaccines in the United States
Amit Srivastava, Amanda F. Dempsey, Alex Galitsky, et al.
BMC Public Health (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 20
A novel hybrid SEIQR model incorporating the effect of quarantine and lockdown regulations for COVID-19
R. Prabakaran, Sherlyn Jemimah, Puneet Rawat, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 18
A Case Report: Multifocal Necrotizing Encephalitis and Myocarditis after BNT162b2 mRNA Vaccination against Covid-19
Michael Mörz
(2022)
Open Access | Times Cited: 12
Tracing the origin of Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2): A systematic review and narrative synthesis
Nagendra Thakur, Sayak Das, Swatantra Kumar, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 12, pp. 5766-5779
Open Access | Times Cited: 12
Heterologous boost with mRNA vaccines against SARS-CoV-2 Delta/Omicron variants following an inactivated whole-virus vaccine
Changrui Lu, Yuntao Zhang, Xiaohu Liu, et al.
Antiviral Research (2023) Vol. 212, pp. 105556-105556
Open Access | Times Cited: 7
Recombinant vaccines: Current updates and future prospects
Vivek Kumar, Anuj A. Verma, Riddhi Singh, et al.
Asian Pacific Journal of Tropical Medicine (2024) Vol. 17, Iss. 8, pp. 338-350
Open Access | Times Cited: 2
SARS-CoV-2 epidemiology, antibody dynamics, and neutralisation capacity in Irish healthcare workers in the era of booster COVID-19 vaccinations
Jonathan McGrath, Claire Kenny, Charlotte Salgaard Nielsen, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 6
Immunotherapy for neuroblastoma using mRNA vaccines
Tanvir Ahmed
Advances in Cancer Biology - Metastasis (2022) Vol. 4, pp. 100033-100033
Open Access | Times Cited: 10
Evaluating the immunogenicity of gold nanoparticles conjugated RBD with Freund's adjuvant as a potential vaccine against SARS-CoV-2
Mahtab Moshref Javadi, Mozhgan Taghdisi Hosseinzadeh, Neda Soleimani, et al.
Microbial Pathogenesis (2022) Vol. 170, pp. 105687-105687
Open Access | Times Cited: 10
Factors and Determinants for Uptake of COVID-19 Vaccine in a Medical University in Riyadh, Saudi Arabia
Bader Al Tulaihi, Khalid G Alharbi, Talal Alaboodi, et al.
Cureus (2021)
Open Access | Times Cited: 12
Eosinophil‐rich linear IgA bullous dermatosis induced by mRNA COVID‐19 booster vaccine
William J. Nahm, Michelle C. Juarez, Julie H. Wu, et al.
Journal of Cutaneous Pathology (2022) Vol. 50, Iss. 1, pp. 24-28
Open Access | Times Cited: 9
A vaccine based on the yeast-expressed receptor-binding domain (RBD) elicits broad immune responses against SARS-CoV-2 variants
Yu Liu, Danhua Zhao, Yi-Chang Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
Thermophilic Filamentous Fungus C1-Cell-Cloned SARS-CoV-2-Spike-RBD-Subunit-Vaccine Adjuvanted with Aldydrogel®85 Protects K18-hACE2 Mice against Lethal Virus Challenge
Ram Nechooshtan, Sharon Ehrlich, Marika Vitikainen, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2119-2119
Open Access | Times Cited: 9
Generation and Characterization of Recombinant Pseudorabies Virus Delivering African Swine Fever Virus CD2v and p54
Jianhui Wei, Chuancheng Liu, Xinyan He, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 335-335
Open Access | Times Cited: 5
Sterilizing Immunity against COVID-19: Developing Helper T cells I and II activating vaccines is imperative
Isaac Kyei-Barffour, Samuel Addo Akwetey, Enoch Aninagyei, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 144, pp. 112282-112282
Open Access | Times Cited: 10
Scope of SARS-CoV-2 variants, mutations, and vaccine technologies
Josephine Wambani, Patrick Okoth
The Egyptian Journal of Internal Medicine (2022) Vol. 34, Iss. 1
Open Access | Times Cited: 7
Impact of the COVID-19 vaccine booster strategy on vaccine protection: a pilot study of a military hospital in Taiwan
Yuli Wang, Shuai-Ru Cheng, Ching‐Fen Shen, et al.
Clinical and Experimental Vaccine Research (2023) Vol. 12, Iss. 4, pp. 337-337
Open Access | Times Cited: 4

Scroll to top